/Investor DB

Canaan Partners — 2025 Investments

22 investments dated 2025 · listed companies and verified rows first · show all

Nocion Therapeuticsnociontx.comin𝕏Series A · Dec 2025 · $27M✓ verified

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(President and Chief Executive Officer)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in

Board seatJulie Grant· per SEC Form D

Co-investorsF-Prime CapitalLumira VenturesMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)

Vivace Therapeuticsvivacetherapeutics.comSeries A · Feb 2025 · $15M✓ verified

Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types.

BiotechHealthtechMedical DevicesSan Mateo, US

Shuang Qiao(Executive Officer, Director)Sheng Ding(Executive Officer)Sofie Qiao(Founder)

BoardEdward Hu(Director)Jun Wu(Director)Jake Simson(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsRA CapitalCenova CapitalMission Biocapital

Draig Therapeuticsdraigtherapeutics.cominSeries A · Jun 2025 · $140M✓ verified

Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders.

BiotechDeep TechDigital HealthMedical DevicesCardiff, GB

John Atack(Head of Biology & Founder)inSimon Ward(Chief Scientific Officer & Founder)in

Co-investorsAccess BiotechnologySanofi VenturesSV Health InvestorsSR One Capital ManagementBritish Business BankCanaan Healthcare+1 more

ThirtyFiveBio Limitedthirtyfivebio.cominApr 2025✓ verified

ThirtyFiveBio is a drug discovery company developing GPR35 antagonists to treat gastrointestinal diseases, with a focus on ulcerative colitis by targeting epithelial dysfunction.

BiotechDigital HealthHealthtechOxford, GB

James Westcott(CEO)in

Aer Therapeuticsaertherapeutics.cominSeries A · Jan 2025 · $36M

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)John Fahy(Director)in

BoardChristy Shaffer(Director)inRishi Gupta(Director)inTim Shannon(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsHatteras Venture PartnersOrbiMedPappas Capital

Journey Livejourney.liveinSeed · Apr 2025 · $2M

Journey is an Employee Assistance Program (EAP) that combines predictive analytics, personalized outreach, and a clinical network — powered by its Journey Signal AI engine — to detect employee mental health risk early and provide proactive care.

AI & Machine LearningEnterprise SoftwareHR TechMental HealthNew York, US

Stephen Sokoler(Founder & CEO)inSue Zbikowski(Chief Clinical Officer)in

BoardJoshua Siegel(Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investors37 AngelsAlumni VenturesBetaworksCity LightCourtside VenturesHealthtech Capital+10 more

OncoResponseoncoresponseinc.comSeries A · Apr 2025 · $14M

Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.

BiotechHouston, US

Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)

BoardSteven Gillis(Director)in

Board seatWende Hutton· per SEC Form D

Co-investors3B Future Health FundGreatPoint VenturesRiverVest Venture PartnersAlexandriaARCH Venture PartnersBering Capital+5 more

Safire Technology Group, Inc.inSeed · Dec 2025 · $8M

Tysons, US

JOHN LEE(Executive Officer, Director)inMICHAEL GRUBBS(Executive Officer, Director)

Board seatHrach Simonian· per SEC Form D

Co-investorsAJINOMOTO CO.,INC.Automotive Ventures MobilityCorrelation VenturesMaC Venture CapitalOUTPOST VENTURES

UrbanSitterurbansitter.comin𝕏Series A · Apr 2025 · $6M

UrbanSitter operates a marketplace platform where families book childcare, tutoring, pet sitting, housekeeping, and senior care services, while caregivers access flexible job opportunities with transparent pay and client reviews.

ConsumerFuture of WorkMarketplacesSan Francisco, US

Lynn Perkins(Co-founder)inAndrea Barrett(Co-founder)inJessica Steel(Executive Officer, Director)in

BoardVincent Caruso(Director)inDavid ibnAle(Director)in

Board seatJohn Balen· per SEC Form D

Co-investorsAdvance Venture PartnersAspect VenturesDBL PartnersFirst Round CapitalOwl CapitalRoyal Street Ventures Management Company, Llc+4 more

Artieartie.comin𝕏Nov 2025

Artie provides a data replication platform built on change data capture (CDC) technology, enabling real-time data movement with sub-minute latency and zero data loss.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Jacqueline Cheong(Co-founder & CEO)inRobin Tang(Co-Founder and CTO)inArmando McIntyre-Kirwin(Executive Officer, Director)Ryan Horrigan(Executive Officer, Director)William Haw(Eng)Nathan Villaescusa(Founding Engineer)

Co-investorsStandard CapitalCalano VenturesFJ LabsGeneral CatalystIA Seed VenturesPathlight Ventures+6 more

CircleUpcircleup.comMay 2025No public record

Not an actual company; "Financial Services" is a sector tag used to describe Sozo Ventures' investment focus areas.

Beaverton, US

Eric Gregg(Executive Officer, Director)inNathan Goff(Executive Officer, Director, Promoter)inAaron Green(Executive Officer, Director)Rory Eakin(Founder)Ryan Caldbeck(Founder)

Co-investorsClocktower VenturesEvolution VC PartnersGV (Google Ventures)Sozo VenturesUnion Square Ventures (USV)QED Investors

Diligent Roboticsdiligentrobots.cominFeb 2025 · $34MAcquired

Diligent Robotics develops AI-powered robot assistants for healthcare settings, focusing on mobile manipulation and social intelligence to help hospital staff with routine non-patient-facing tasks.

AI & Machine LearningHealthtechMedical DevicesRoboticsAustin, US

Andrea L. Thomaz(Founder)inVivian Chu(Founder)inAndrea Thomaz(Founder)

BoardQuaeed Motiwala(Director)Rohit Sharma(Director)inLance VandenBrook(Director)

Co-investorsATPCorrelation VenturesDnx VenturesGaingelsGrit VenturesInterwoven Ventures+12 more

DoorStepdoorstep.aiin𝕏Seed · Sep 2025 · $8M

Doorstep offers an SDK that uses smartphone sensor fusion to detect delivery events indoors in GPS-degraded environments, tracking parking, entrance, floor, and drop-off details.

AI & Machine LearningDeveloper ToolsLogistics & Supply Chain

Shashwat M.(Founder)inSheel Patel(Founder)inShashwat Murarka(Founder)

Co-investorsAntler

Normunitynormunity.comin𝕏Series A · Jan 2025 · $65M

Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance.

BiotechHealthtech

Rachel Humphrey(Founding Chief Executive Officer)inLieping Chen(Scientific Founder)Mitchell Keegan(Chief Development Officer)inWilliam LaRochelle(Chief Scientific Officer)inStacy M. Plum(Chief Technology Officer)

Co-investorsSanofi VenturesTaiho Ventures, LLCPfizer VenturesSamsara BioCapitalConnecticut InnovationsOUP (Osage University Partners)+6 more

Novee Securitynovee.securitySeries A · Sep 2025 · $33M

Novee is a Tel Aviv-based cybersecurity startup that built an AI-driven penetration testing platform acting as an autonomous "AI hacker" to continuously find and fix vulnerabilities in changing business environments.

Gon Chalamish(Founder)Ido Geffen(Founder)Omer Ninburg(Founder)

Co-investorsICON - Israel Collaboration NetworkYL VenturesZeev Ventures

Quarry Theraquarrythera.cominFeb 2025

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds.

BiotechDeep TechNew Haven, US

Craig Crews(Co-Founder & Scientific Advisor)inMikael Dolsten, M.D., Ph.D.(Co-founder and Executive Chairman of the Board)Craig Crews, Ph.D.(Co-Founder & Scientific Advisor)Dan McHugh(Manager)Tim Shannon(CEO and Board Member)inJeanne Magram(Chief Scientific Officer)in

Co-investorsYosemiteF-Prime CapitalLilly Ventures

Sumblesumble.comOct 2025

Sumble provides GTM teams with a structured view of target accounts, mapping teams, reporting lines, technologies in use, hiring activity, and buying signals so reps can identify decision-makers and personalize outreach.

Data & InfrastructureSaaSSales TechSan Francisco, US

Anthony Goldbloom(Founder)inBen Hamner(Founder)in

Co-investorsAIX VenturesBloomberg BetaCoatue ManagementOctaveSquare Peg CapitalVery Serious Ventures+2 more

Triton Therapeutics, Inc.tritonthera.comOct 2025

Triton Therapeutics is a clinical-stage biotechnology company developing first-in-class medicines for autoimmune and fibrotic diseases.

BiotechHealthtechStamford, US

BoardAnnie Mitsak(Director)inTimothy Shannon(Director)Elena Grigoryeva(Director)Paul Fonteyne(Executive Officer, Director)in

Co-investorsCure Ventures

Trotana Therapeuticstrotana.comJan 2025

San Diego biotech founded in 2019 developing oral anti-inflammatory small molecules targeting RNA binding proteins.

Co-investorsARCH Venture PartnersLightstone VenturesMedical Excellence Capital

Wise Layerwiselayer.comin𝕏Seed · Jan 2025 · $7.2Macquired by BlackLine

WiseLayer builds AI agents that automate specific complex tasks for finance and accounting teams, such as accruals and payroll accounting.

AI & Machine LearningFintechSaaS

Therese Tucker(Founder & Co-CEO)

Co-investorsPerkins Cove PartnersK5 GlobalThe Fintech FundUnpopular VenturesUnusual Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Clutch Technologies Inc.Cloud Captain

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.